Literature DB >> 8694046

A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion.

J K Jain1, D R Mishell.   

Abstract

OBJECTIVE: Our purpose was to determine whether intracervical placement of laminaria tents would improve the effectiveness of the prostaglandin analog misoprostol for the elective termination of pregnancies in the second trimester. STUDY
DESIGN: Sixty-eight women between 12 and 22 weeks of gestation with either an intrauterine fetal death (n = 40) or medical or genetic indications for pregnancy termination (n = 30) were randomized to receive 200 micrograms of misoprostol administered vaginally every 12 hours with or without intracervical placement of laminaria concurrently with the first dose of misoprostol.
RESULTS: The rate of abortion 24 hours after initiation of treatment was 69.7% in the 33 women receiving misoprostol alone and 68.6% in the 35 women treated with misoprostol and laminaria. The abortion rates 48 hours after initiation of treatment were 84.8% and 91.4%, respectively, an insignificant difference. The complete abortion rate was also similar between women receiving misoprostol alone (39.3%) and the group receiving misoprostol and laminaria (37.5%). There were no significant differences in the incidence of fever, vomiting, diarrhea, or pain. The mean interval from initiation of treatment to abortion was also similar, 15.7 hours in those receiving misoprostol alone and 17.4 hours in those treated with misoprostol and laminaria. In both groups women who had live fetuses at the start of the procedure had a higher failure rate of abortion and a longer time interval to abortion than women whose fetus was dead.
CONCLUSIONS: Laminaria tents inserted concurrently with the first dose of misoprostol do not significantly improve the abortifacient effect of vaginal misoprostol in the second trimester of pregnancy.

Entities:  

Keywords:  Abortion, Drug Induced; Abortion, Induced; Americas; Biology; California; Cervical Dilatation; Developed Countries; Endocrine System; Family Planning; Fertility Control, Postconception; Laminaria Tents; Misoprostol; North America; Northern America; Physiology; Prostaglandins; Prostaglandins, Synthetic; Research Report; Treatment; United States

Mesh:

Substances:

Year:  1996        PMID: 8694046     DOI: 10.1016/s0002-9378(96)70270-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.

Authors:  Francis S Nuthalapaty; Patrick S Ramsey; Joseph R Biggio; John Owen
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

Review 2.  Medical treatments for incomplete miscarriage (less than 24 weeks).

Authors:  James P Neilson; Gillian Ml Gyte; Martha Hickey; Juan C Vazquez; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 3.  Medical treatments for incomplete miscarriage.

Authors:  Caron Kim; Sharmani Barnard; James P Neilson; Martha Hickey; Juan C Vazquez; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

Review 4.  Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death.

Authors:  Jodie M Dodd; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

5.  Medical treatment for early fetal death (less than 24 weeks).

Authors:  Marike Lemmers; Marianne Ac Verschoor; Bobae Veronica Kim; Martha Hickey; Juan C Vazquez; Ben Willem J Mol; James P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

6.  Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis.

Authors:  Hang-Lin Wu; Sheeba Marwah; Pei Wang; Qiu-Meng Wang; Xiao-Wen Chen
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

7.  Intravaginal isonicotinic acid hydrazide (INH) versus misoprostol for cervical ripening prior to hysteroscopy.

Authors:  Ladan Haghighi; Zahra Najmi; Samaneh Rokhgireh; Yousef Moradi
Journal:  Obstet Gynecol Sci       Date:  2020-06-19

8.  Methods for managing miscarriage: a network meta-analysis.

Authors:  Jay Ghosh; Argyro Papadopoulou; Adam J Devall; Hannah C Jeffery; Leanne E Beeson; Vivian Do; Malcolm J Price; Aurelio Tobias; Özge Tunçalp; Antonella Lavelanet; Ahmet Metin Gülmezoglu; Arri Coomarasamy; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2021-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.